We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metastasis Enablers: Key to Creating Ovarian Cancer Treatments

News   May 09, 2018 | Original story from University of Wisconsin–Madison

 
Metastasis Enablers: Key to Creating Ovarian Cancer Treatments

Biomedical engineering professor Pam Kreeger and other lab members have teased out how one type of immune cells helps cancer cells attach in the peritoneal cavity, enabling metastasis. Credit: UW-Madison

 
 
 

RELATED ARTICLES

Cytokine Signature Helps Target Advanced Breast Cancer

News

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

READ MORE

Ovarian Cancer Biomarker Can Predict Patient Therapy Response

News

Researchers have identified an independent prognostic factor - cancer/testis antigen 45 (CT45) - and have begun to elucidate it's actions. CT45 is associated with extended disease-free survival for women with advanced ovarian cancer.

READ MORE

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE